Unknown substance blocks the immune system's signaling pathway.

Published Date: 25 Oct 2023

For the first time, researchers from CeMM, the Medical University of Vienna, and the University of Lausanne have successfully discovered and described a novel small molecule called "Feeblin" that has the ability to inhibit the interaction.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium

2.

The main subject is associated with suicide in the United States.

3.

Alkem introduces cetuximab under the trade name Cetuxa in India.

4.

Firefighters who eat better can combat cancer.

5.

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot